Dosimertinib-d 5 mesylate

Overview

Dosimertinib-d 5 (mesylate) is a potent and orally active EGFR inhibitor . Dosimertinib-d 5 (mesylate) decreases the expression of p-EGFR and p-ERK protein levels. Dosimertinib-d 5 (mesylate) shows antiproliferative and anti-tumor activity. Dosimertinib-d 5 (mesylate) has the potential for the research of non-small-cell lung cancer (NSCLC).

Application

Products | Products > Disease Areas > Cancer | Products > Disease Areas > Lung Cancer | Products > Signaling Pathways > JAK/STAT Signaling | Products > Signaling Pathways > Protein Tyrosine Kinase/RTK | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Signaling Pathways > EGFR

Product Information

• Catalog No.: HY-142283AS
• CAS No.: 2403760-72-3
• Molecular Formula: C29H32D5N7O5S
• Molecular Weight: 600.74
• Purity: 99.50%
• Storage: -20°C, sealed storage, away from moisture * In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)
• Availability: In-stock

Source

Original product source